Pacira BioSciences 第四季度调整后每股收益 $0.91 超预期 $0.84,销售额 $1.8725 亿超预期 $1.8436 亿

财报速递2025-02-28
Pacira BioSciences(NASDAQ:PCRX)公布季度每股收益为 $0.91,较分析师一致预期的 $0.84 高出 8.33%。与去年同期的 $0.89 相比增长 2.25%。公司报告季度销售额为 $1.8725 亿,较分析师一致预期的 $1.8436 亿高出 1.57%。相比去年同期的 $1.8124 亿,销售额增长了 3.32%。

以上内容来自Benzinga Earnings专栏,原文如下:

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.84 by 8.33 percent. This is a 2.25 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $187.25 million which beat the analyst consensus estimate of $184.36 million by 1.57 percent. This is a 3.32 percent increase over sales of $181.24 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法